Nuo Therapeutics, Inc.

AURX OTC CIK: 0001091596

Company Information

Industry Surgical & Medical Instruments & Apparatus
SIC Code 3841
Entity Type operating
SEC Category Non-accelerated filerSmaller reporting company
State of Incorporation DE
Business Address 8285 EL RIO, HOUSTON, TX, 77054
Mailing Address 8285 EL RIO, HOUSTON, TX, 77054
Phone 832-236-9060
Fiscal Year End 1231
EIN 233011702

Financial Overview

FY2025

$2.80M
Total Liabilities

Recent SEC Filings

Form Type Date Filed Document
10-K Annual financial report March 30, 2026 View on SEC
SCHEDULE 13G/A Passive ownership amendment February 12, 2026 View on SEC
4 Insider stock transaction report January 26, 2026 View on SEC
SCHEDULE 13D/A Beneficial ownership amendment January 26, 2026 View on SEC
8-K Current report of material events January 26, 2026 View on SEC
4 Insider stock transaction report January 5, 2026 View on SEC
4 Insider stock transaction report December 22, 2025 View on SEC
8-K Current report of material events December 17, 2025 View on SEC
4 Insider stock transaction report December 11, 2025 View on SEC
4/A Insider transaction amendment December 11, 2025 View on SEC

Annual Reports

10-K March 30, 2026
  • Revenue surged 121% year-over-year to $3.1 million in 2025.
  • Strategic distribution partnership secured with global leader Smith+Nephew.
View Analysis

Related Companies

Companies in the same industry (SIC: 3841)

Investor Resources

Learn more about SEC filings and how to research public companies.

Important Disclaimer

This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.